Birte Wistinghausen, MD

Birte Wistinghausen, M.D., is a pediatric oncologist and member of the leukemia and lymphoma team. She treats children, adolescents and young adults with non-Hodgkin lymphoma (NHL), histiocytosis and leukemia. Her clinical research concentrates on non-Hodgkin lymphoma, specifically on the role of Epstein-Barr virus (EBV) in Post-Transplant Lymphoproliferative Syndrome (PTLD) and cellular therapy in EBV-positive PTLD as well as the biology and treatment of B-lymphoblastic lymphoma.

Dr. Wistinghausen's roles within the Children’s Oncology Group (COG) include serving as the principal co-investigator of a clinical study using EBV-specific T-cells in patients with post-transplant lymphoproliferative disease and being the responsible investigator for B-lymphoblastic lymphoma. She is also serving as vice-chair for education of the COG NHL committee.